Sj. Gallacher et al., ACUTE EFFECTS OF INTRAVENOUS 1-ALPHA-HYDROXYCHOLECARCIFEROL ON PARATHYROID-HORMONE, OSTEOCALCIN AND CALCITRIOL IN MAN, European journal of endocrinology, 130(2), 1994, pp. 141-145
The acute effects of a single intravenous injection of 2 mu g of 1 alp
ha-hydroxycholecalciferol (alfacalcidol) were studied for a 24-h perio
d in six normal males (mean age 33 years), six women with primary hype
rparathyroidism (mean age 72 years) and six women with established ost
eoporosis (mean age 63 years). In all three groups, serum calcitriol l
evels rose to a peak 2-3 h after administration of alfacalcidol. Basal
levels were highest in the primary hyperparathyroidism group at (mean
+/-SEM) 81+/-2 vs 62+/-12 (normal males) (p<0.05) and 56+/-5 pmol/l (o
steoporosis) (p<0.01). Highest peak levers were found also in the prim
ary hyperparathyroidism group at 150+/-15 vs 114+/-15 (normal males) (
p<0.05) and 127+/-15 pmol/l (osteoporosis) (p<0.01). The rise in calci
triol was higher in the primary hyperparathyroidism group than either
the normal males or osteoporotic patients (p<0.05). No significant dif
ferences were evident in basal serum calcidiol concentrations among th
e three treatment groups. As might be expected, highest basal concentr
ations of parathyroid hormone (PTH), serum calcium and serum osteocalc
in were noted in the primary hyperparathyroid group (PTH: 17.1+/-7.7 v
s 1.9+/-0.5 (normal males) (p<0.01) and 2.1+/-0.3 pmol/l (osteoporosis
) (p<0.01); calcium: 3.06+/-0.08 vs 2.50+/-0.02 (normal males) (p<0.01
) and 2.43+/-0.02 mmol/l (osteoporosis) (p<0.01); osteocalcin: 1.10+/-
0.08 vs 0.56+/-0.16 (normal males) (p<0.05) and 0.53+/-0.21 nmol/l (os
teoporosis) (p<0.05). Following treatment with alfacalcidol, no signif
icant change was observed in PTH, calcium or osteocalcin serum concent
rations in any group. These results show that maximal conversion of al
facalcidol to calcitriol occurs within a few hours of administration o
f alfacalcidol in normal males and patients with primary hyperparathyr
oidism and osteoporosis. Whilst this may reflect differences in activi
ty of the enzyme 25-hydroxylase among these groups, other explanations
, such as differences in calcitriol clearance, cannot be excluded.